Johanna Hynninen

Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines. (2018)

Clinical Cancer Research

Roering P, Mikkonen P, Potdar S, Wennerberg K, Hynninen J, Grenman S, Auranen A, Carpen O, Kaipio K

(Muu (O2))

F-18-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer (2018)

European Journal of Nuclear Medicine and Molecular Imaging

Vallius T, Hynninen J, Kemppainen J, Alves V, Auranen K, Matomäki J, Oksa S, Virtanen J, Grénman S, Auranen A, Seppänen M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)

Clinical Cancer Research

Huhtinen K, Gidwani K, Kekki H, Hynninen J, Salminen L, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, Pettersson K

(Muu (O2))

Identifying differentially methylated sites in samples with varying tumor purity (2018)

Bioinformatics

Antti Häkkinen, Amjad Alkodsi, Chiara Facciotto, Kaiyang Zhang, Katja Kaipio, Sirpa Leppä, Olli Carpén, Seija Grénman, Johanna Hynninen, Sakari Hietanen Rainer Lehtonen, Sampsa Hautaniemi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer (2018)

Clinical Cancer Research

Isoviita VM, Salminen L, Azar J, Hynninen J, Lehtonen R, Roring P, Grenman S, Farkkila A, Hautaniemi S

(Muu (O2))

Clinical Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer (2018)

Clinical Oncology

J. Hynninen, M. Laasik, T. Vallius, J. Kemppainen, S. Grönroos, J. Virtanen, J. Casado, S. Hautaniemi, S. Grenman, M. Seppänen, A. Auranen

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Gynekologiset syövät (2018)

Johanna Hynninen, Johanna Virtanen, Marko Seppänen

(Artikkeli ammatillisessa kokoomateoksessa (D2))

High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment (2018)

Clinical Cancer Research

Dai J, Erkan EP, Zhang KY, Kaipio K, Lamminen T, Huhtinen K, Hynninen J, Grenman S, Carpen OM, Hautaniemi S, Vaharautio A

(Muu (O2))

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)

Clinical Cancer Research

Tumiati M, Hietanen S, Hynninen J, Pietilä E, Färkkilä A, Kaipio K, Roering P, Huhtinen K, Alkodsi A, Li Y, Lehtonen R, Erkan EP, Tuominen MM, Lehti K, Hautaniemi SK, Grénman S, Vähärautio A, Carpén O, Kauppi L

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)

International Journal of Gynecological Cancer

Salminen L, Gidwani K, Rolfsen AL, Nadeem N, Bolstad N, Dorum A, Grenman S, Hietanen S, Perheentupa A, Poutanen M, Carpen O, Lamminmaki U, Pettersson K, Hynninen J, Huhtinen K

(Muu (O2))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines. (2018)

F-18-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer (2018)

A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)

Identifying differentially methylated sites in samples with varying tumor purity (2018)

Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer (2018)

Clinical Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer (2018)

Gynekologiset syövät (2018)

High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment (2018)

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)

CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)